foxo4-dri senolytic or senomorphic

foxo4-dri senolytic or senomorphic The disordered p53 transactivation domain is the target of FOXO4 and the compound Targeting cellular senescence with senotherapeutics:

Name: foxo4-dri senolytic or senomorphic The disordered p53 transactivation domain is the target of FOXO4 and the compound Targeting cellular senescence with senotherapeutics:
Brand: iglepidom.org
SKU: 28102934640
Price: 29.36 USD
Availability: InStock
Rating: 4.4203 (9 reviews)

Targeting cellular senescence with senotherapeutics: senolytics and senomorphics Zhang 2023 The FEBS Journal Wiley Online Library CHK2 USP37 axis stabilizes FOXO4 to sustain senescence and evade apoptosis PNAS Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging PMC Senolytics: charting a new course or enhancing existing anti tumor therapies? Cellular Oncology Springer Nature Link

SKU: 28102934640 · From iglepidom.org

4.4

USD29.36 USD62.36

Pay in 4 interest-free payments of $7.34 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

Outcomes of early versus late functional weight-bearing after the acute Achilles tendon rupture repair with minimally invasive surgery: a randomized controlled trial